Thursday, May 19, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Potential molecular and clinical biomarkers of COVID-19 severity

by Medical Finance
in Coronavirus
Study: Molecular and Clinical Prognostic Biomarkers of COVID-19 Severity and Persistence. Image Credit: Fotomay/Shutterstock
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

Coronavirus disease 2019 (COVID-19) first emerged in Wuhan, China, and has since spread to nearly every country in the world. Initially, the lack of available treatments and tests for the disease forced many countries to enact costly and restrictive measures to prevent the rapid transmission of the disease. These included mandatory face masks, social distancing laws, and even the introduction of full lockdowns/stay-at-home orders.

Study: Molecular and Clinical Prognostic Biomarkers of COVID-19 Severity and Persistence. Image Credit: Fotomay/Shutterstock
Study: Molecular and Clinical Prognostic Biomarkers of COVID-19 Severity and Persistence. Image Credit: Fotomay/Shutterstock

While mass vaccination programs in developed nations have helped curb the severity of the disease, threats remain from emerging variants, and developing nations have struggled to achieve the necessary nationwide vaccination levels to pass the herd immunity threshold. However, scientists continue to study the disease to help healthcare workers and patients. In an article published in Pathogens, researchers have reviewed the currently published data examining the potential molecular and clinical biomarkers of COVID-19 severity.

The review

Changes in cell populations have been often linked to disease severity, including changes such as lymphopenia, increases in neutrophil count/neutrophil to lymphocyte ratio (NLR), higher levels of white blood cells (WBCs), and thrombocytopenia. Inflammatory markers found in the blood have also repeatedly been found to rise in cases that end with a worse outcome. In those that do not survive, it is typical to see high levels of D-dimer, PT, alanine transaminase (ALT), and quick reductions in the levels of fibrinogen, while elevated levels of IL-6, IL-10, ESR, and PCT indicate that the patient is likely to progress to more severe disease.

The proportion of neutrophils in COVID-19 patients is another factor that can provide insight into the severity of COVID-19. Patients hospitalized with severe disease have higher levels of CD16low and CD16int than mild and moderate cases. Classical and immature monocytes such as CD14+ or CD14++CD16- are often seen in more severe cases, and higher proportions of CD1aCD14+ and other monocytes that express ALCAM are associated with patients that will suffer from an adverse reaction within 30 days.

Severe patients also tend to show decreased natural killer cell populations upon hospital admission – but there is a significant increase in natural killer cells activated. As expected with an inflammatory disease, elevated proportions of B cells are often seen in severe or critical disease patients.

Viral titers are normally higher in severe viral disease, and COVID-19 infection follows this pattern. Higher RNA loads are significantly higher in the plasma of patients that do not survive compared to other patients, with non-survivors averaging around 1,587copies/mL of the N1 region and 2,798 copies/mL of the N2 region, while survivors showed viral loads of 574 copies/mL and 523 copies/mL, respectively. Other studies found that genes encoding the regions of IgA1, IgA2, IgG1, and IgG2 were upregulated in plasma B cells in severe patients.

COVID-19 patients who need admission to the ICU show different gene expression levels compared to milder cases, specifically showing upregulation of ELANE, OLFM4, MPO, RETN, ARG1, CD177, S100A12. Many of these are associated with granulocytes or granulocyte activation. Further investigation of the granulocyte transcriptome in the day following hospitalization revealed upregulation of genes encoding matrix metallopeptidase 9/25 in neutrophils and macrophages – associated in severe patients with leukocyte migration to inflamed sites. CD15, S100A8/9, PADI4, NLRC4, MMP8, and MMP9 were also upregulated.

Gene ontology analysis further revealed differentially expressed genes in the regulation of the inflammatory responses, as well as the cellular response to IL-1 and tumor necrosis factor. Both IL1Beta and IL-6 show overexpression in severe cases of COVID-19 compared to milder disease, while the anti-inflammatory IL-10 is downregulated. Other patients reporting severe disease show high levels of TNF-alpha and CXCL10 that can remain high for weeks following infection – the original researchers suggested that this could be at least partially responsible for the difficulty in concentration seen in many ‘long-COVID’ patients.

Conclusion

The authors highlight that while the standard biomarkers found in blood tests can continue to act as effective biomarkers for the severity of infection with COVID-19, many alternate candidates exist, including cell population subsets and transcriptomic signatures. The dynamic changes in biomarker levels could be very useful for healthcare workers and COVID-19 researchers and could help both identify possible drug targets as well as potentially help to triage cases if another serious epidemic breaks out.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: First Evidence of Natural SARS-CoV-2 Infection in Domestic Rabbits. Image Credit: Evgeniy Goncharov photo/Shutterstock

Researchers explore natural SARS-CoV-2 infection in pet rabbits in France

by Medical Finance
May 19, 2022
0

In a recent study posted to the journal Veterinary Sciences, researchers reported the first evidence of natural severe acute respiratory syndrome...

Study: Structural diversity of the SARS-CoV-2 Omicron spike. Image Credit: Naeblys/Shutterstock

Illustrating the structural diversity of SARS-CoV-2 Omicron spike

by Medical Finance
May 19, 2022
0

In a recent study posted to the bioRxiv* pre-print server, a team of researchers used cryo-electron microscopy (cryo-EM) to determine...

Study: The SARS-CoV-2 protein NSP2 impairs the microRNA-induced silencing capacity of human cells. Image Credit: Kateryna Kon/Shutterstock

SARS-CoV-2 protein NSP2 found to impair microRNA-induced gene silencing in human cells

by Medical Finance
May 19, 2022
0

A team of researchers used co-immunoprecipitation (co-IP) and in vitro interaction assays to identify the molecular basis of interaction of...

Study: SARS-CoV-2 Omicron Variant AI-based Primers. Image Credit: Naeblys/Shutterstock

Impact of using AI to generate primers for detection of SARS-CoV-2 Omicron variant

by Medical Finance
May 19, 2022
0

In a recent study posted to the bioRxiv* preprint server, researchers designed artificial intelligence (AI)-based primers for the severe acute...

Study: Anti-SARS-CoV-2 swine glyco-humanized polyclonal antibody XAV-19 retains neutralizing activity against SARS-CoV-2 B.1.1.529 (Omicron). Image Credit: Design_Cells/Shutterstock

Assessing the neutralizing ability of polyclonal antibody XAV-19 against SARS-CoV-2 Omicron variant

by Medical Finance
May 19, 2022
0

In a recent study posted to the bioRxiv* pre-print server, a team of researchers assessed the neutralizing activity of XAV-19,...

Study: Impact of various vaccine boosters on neutralization against Omicron following prime vaccinations with inactivated or adenovirus-vectored vaccine. Image Credit: Komsan Loonprom/Shutterstock

Assessing the effects of booster vaccinations against SARS-CoV-2 Omicron variant

by Medical Finance
May 19, 2022
0

In a recent study posted to the bioRxiv* preprint server, researchers analyzed the effect of vaccine booster doses against the...

Next Post
Bacterial biofilms use a developmental patterning mechanism seen in plants and animals

Rising temperatures lead to increased prevalence of Vibrio bacteria in UK waters

Study: Protection afforded by prior infection against SARS-CoV-2 reinfection with the Omicron variant. Image Credit: creativeneko/Shutterstock

Effectiveness of prior infection in preventing reinfection with Omicron and other SARS-CoV-2 variants in Qatar

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • 3d rendered illustration molecules Sebastian Kaulitzki 2000 12b7886e43a74db8bd94fd774ce58a26 620x480
    Novel molecule shows ability to inhibit the replication of all coronaviruses
  • Study: Β-Amyloid Deposits in Young COVID Patients. Image Credit: Kateryna Kon / Shutterstock.com
    Beta-amyloid deposits found in young patients with COVID-19
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply